Leslie J. Padrnos, M.D.

  1. Padrnos L, Mesa R. Novel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials. Expert Opin Investig Drugs. 2020 Jun 17 Epub 2020 June 17
    View PubMed
  2. Gonzalez-Velez M, Mead-Harvey C, Kosiorek HE, Kusne YN, Rivera C, Bojanini L, Northfelt DW, Padrnos LJ. Racial/ethnic differences in patients with anemia and folate deficiency. Int J Lab Hematol. 2020 Apr 16 [Epub ahead of print]
    View PubMed
  3. Padrnos LJ, Houghton OM, Iacob CE, Kurli M, Ocal IT, Bryce AH. Genomic profiling proves metastasis of cutaneous melanoma to vitreal fluid. Melanoma Res. 2020 Feb 17 [Epub ahead of print]
    View PubMed
  4. Padrnos L, Ernst B, Dueck AC, Kosiorek HE, Ginos BF, Toro A, Johnston PB, Habermann TM, Leis JF, Mikhael JR, Nowakowski GS, Colgan J, Porrata L, Ansell SM, Witzig TE, Reeder C. A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma. Clin Lymphoma Myeloma Leuk. 2018 Oct; 18 (10):664-672.e2 Epub 2018 June 15
    View PubMed
  5. Padrnos LJ, Garcia D. May Thurner Syndrome and Thrombosis: A Systematic Review of Antithrombotic Use after Endovascular Stent Placement. Research and Practice in Thrombosis and Haemostasis. (accepted). 2018.
  6. Padrnos L, Bennett R, Kosiorek H, Dueck AC, Northfelt D, Mikhael J, Tibes R, Khera N, Mesa RA. Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit. J Cancer Educ. 2018 Jun; 33 (3):653-659
    View PubMed
  7. Padrnos L, Mesa RA. Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of Life. Oncology (Williston Park). 2017 Jul 15; 31 (7):521-9
    View PubMed
  8. Thind K, Padrnos LJ, Ramanathan RK, Borad MJ. Immunotherapy in pancreatic cancer treatment: a new frontier. Therap Adv Gastroenterol. 2017 Jan; 10 (1):168-194 Epub 2016 Oct 17
    View PubMed
  9. Padrnos L, Karlin N, Halfdanarson TR. Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012. Rare Tumors. 2016 Nov 17; 8 (4):6804
    View PubMed
  10. Padrnos LJ, Adamski J. Understanding laboratory test limitations can improve accuracy in diagnosing heparin induced thrombocytopenia. ASCP Case Report Transfusion Medicine Series. (accepted). 2016.
  11. Padrnos LJ, Barr PJ, Klassen CL, Fields HE, Azadeh N, Mendoza N, Saadiq RA, Pauwels EM, King CS, Chung AA, Sakata KK, Blair JE. Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project. BMJ Qual Improv Rep. 2016; 5 (1) Epub 2016 May 05
    View PubMed
  12. Padrnos L, Dueck AC, Scherber R, Glassley P, Stigge R, Northfelt D, Mikhael J, Aguirre A, Bennett RM, Mesa RA. Quality of life and disease understanding: impact of attending a patient-centered cancer symposium. Cancer Med. 2015 Jun; 4 (6):800-7 Epub 2015 Jan 30
    View PubMed
  13. Padrnos LJ, Blair JE, Kusne S, DiCaudo DJ, Mikhael JR. Cutaneous legionellosis: case report and review of the medical literature. Transpl Infect Dis. 2014 Apr; 16(2):307-14. Epub 2014 Mar 17.
    View PubMed
  14. Padrnos L, Mesa RA. A closer look at pacritinib: A JAK2/FLT3 inhibitor for the treatment of myelofibrosis. Expert Opinion on Orphan Drugs. 2014; 2(7):725-33.
  15. Padrnos L, Bui T, Pattee JJ, Whitmore EJ, Iqbal M, Lee S, Singarajah CU, Robbins RA. Analysis of overall level of evidence behind the Institute of Healthcare Improvement ventilator-associated pneumonia guidelines. Southwest J Pulm Crit Care. 2011 Aug 3; 3:40-8.